OPTIMIZATION OF TREATMENT FOR METABOLIC SYNDROME STEATOGEPATITIS
Keywords:
Dietary changes, Physical activity, Weight loss, Insulin sensitizers, Hypolipidemic agents.Abstract
Optimizing treatment for metabolic syndrome-associated steatohepatitis (NASH) requires a multifaceted approach that targets the underlying factors contributing to both the metabolic syndrome and the liver disease. Metabolic syndrome, which includes conditions such as obesity, insulin resistance, dyslipidemia, and hypertension, predisposes individuals to Non-Alcoholic Fatty Liver Disease (NAFLD), with the most severe form being Non-Alcoholic Steatohepatitis (NASH), where liver inflammation and damage occur. The treatment of NASH associated with metabolic syndrome involves lifestyle modifications, pharmacotherapy, and in some cases, interventions targeting specific disease pathways.
References
Batskov S.S. Liver diseases in the practice of an outpatient therapist / S.S. Batskov. — St. Petersburg: LLC "SLP" — 1999. — 120 p.
Belyakov H.A. Metabolic syndrome in women (pathophysiology and clinic) / H.A. Belyakov, G.B. Seidova, S.Y. Chubrieva, N.V. Glukhov; edited by H.A. Belyakov— St. Petersburg: Publishing House SPb MALO, 2005.— 440 p.
Bogomolov P.O. Non-alcoholic fatty liver disease: steatosis and non-alcoholic steatohepatitis / P.O. Bogomolov, Yu.O. Shulpekova // Clinical perspectives of gastroenterology, hepatology, 2004. — No. 3. — pp. 20-27.
Bueverov A.O. Nonalcoholic steatohepatitis / A.O. Bueverov, M.V. Mayevskaya, E.N. Shirokova; edited by V.T. Ivashkin. Moscow, 2005-16 p.
Butrova S.A. Metabolic syndrome: pathogenesis, clinic, diagnosis, treatment approaches / S.A. Butrova // Russian Medical Journal, 2001. No. 9. pp.56-60.
Vinnitskaya E.V. Alcoholic and non-alcoholic steatohepatitis / E.V. Vinnitskaya, L. Y. Ilchenko, S.G. Khomeriki // Experimental and Clinical Gastroenterology (Abstracts of articles submitted to the 4th Congress of the NOGR), 2004, No. 1, pp. 74-79.
Grigoriev P.Ya. Fatty hepatosis (fatty liver infiltration): diagnosis, treatment and prevention. — Electron, dan. — 2004. — Access mode: htpp//www.rsl.ru, free. — Caption from the screen
Zvenigorodskaya L.A. Clinical and morphological changes in the liver in patients with dyslipoproteinemia / L.A. Zvenigorodskaya, N.V. Baburova, S.D. Shepeleva, V.D. Tkachev // Experimental and clinical gastroenterology, 2002. — №3. — pp. 29-32.
Ilyushina T.B. Diagnostic possibilities of radiation research methods in the detection of fatty liver / T.V. Ilyushina, V.A. Ratnikov, A.N. Kovalev, S.K. Skulsky // Experimental and Clinical Gastroenterology (Abstracts of articles submitted to the 4th Congress of the NOGR), 2004, No. 1, pp.74-79.
Yu.Lazebnik L.B. Metabolic syndrome / L.B. Lazebnik, L.A. Zvenigorodskaya, E.G. Egorova // Hepatology, 2004. No. 3. pp. 4-15.
Mayansky D.N. New frontiers of hepatology / D.N. Mayansky, E. Visse, K. Decker; Russian Academy of Medical Sciences, Siberian Branch. — Novosibirsk. - 1992. — 264 p.
Melnikova N.V. Clinical and biochemical changes and morphological features of the liver in patients with dyslipoproteinemia / N.V. Melnikova, L.A. Zvenigorodskaya, S.G. Khomeriki // Hepatology, 2004. No. 3. pp. 18-21.
Nikitin I.G. Dufalac (lactulose) in the treatment of intestinal dysbiosis in nonalcoholic steatohepatitis / I.G. Nikitin, G.I. Storozhakov, I.G. Fedorov, C.B. Lepkov, N.V. Petrenko, V.M. Volinkina, E.V. Modestova, O.A. Kondrakova, M.P. Gusarova // Clinical perspectives of gastroenterology and hepatology, 2002, No. 1, pp. 24-29.
Petukhov V.A. Liver dysfunction and dysbiosis in Savelyev's lipid distress syndrome and their correction with the prebiotic Hilak-forte / V.A. Petukhov // Russian Medical Journal, 2002. Vol. 10, No. 4. pp. 158-162.
Savelyev B.C. Lipid distress syndrome in surgery / B.C. Saveliev, E.G. Yablokov, V.A. Petukhov // Bulletin of Experimental Biology and Medicine, 1999, vol. 127, No. 6, pp. 604-611.
